Immunotherapy

eISSN: 1750-7448pISSN: 1750-743X

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
5.7
Eigenfactor
0.005 - 0.01
H-Index
59
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.7

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
  • Publisher
    FUTURE MEDICINE LTD
  • Language
    English
  • Frequency
    Semi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Cancer
Immunotherapy
Lung cancer
Psoriatic arthritis
Progression-free survival
Systematic review
Psoriasis
Immune checkpoint inhibitors
Renal carcinoma
Hepatocellular carcinoma
Overall survival
Breast cancer
Chimeric antigen receptor
Immune checkpoint
Pneumothorax
Pembrolizumab
Primary immunodeficiency
Eosinophilic
Photopheresis
Adjuvant therapy

Recently Published Papers

Year-wise Publication

FAQs

Since when has Immunotherapy been publishing? Faqs

The Immunotherapy has been publishing since 2009 till date.

How frequently is the Immunotherapy published? Faqs

Immunotherapy is published Semi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Immunotherapy? Faqs

Immunotherapy has a H-index score of 59, Citescore of 5.7, SNIP score of 0.7, & SJR of Q2

Who is the publisher of Immunotherapy? Faqs

The publisher of Immunotherapy is FUTURE MEDICINE LTD.

How can I view the journal metrics of Immunotherapy on editage? Faqs

For the Immunotherapy metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Immunotherapy? Faqs

The eISSN number is 1750-7448 and pISSN number is 1750-743X for Immunotherapy.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Immunotherapy, Lung cancer, Psoriatic arthritis, Progression-free survival, Systematic review, Psoriasis, Immune checkpoint inhibitors, Renal carcinoma, Hepatocellular carcinoma, Overall survival, Breast cancer, Chimeric antigen receptor, Immune checkpoint, Pneumothorax, Pembrolizumab, Primary immunodeficiency, Eosinophilic, Photopheresis, Adjuvant therapy.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.